<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>APh, vol. 36(3)</title>
<link>https://hdl.handle.net/10481/74574</link>
<description/>
<pubDate>Tue, 07 Apr 2026 01:48:46 GMT</pubDate>
<dc:date>2026-04-07T01:48:46Z</dc:date>
<item>
<title>Structure - activity studies with histamine H3 - receptor ligands</title>
<link>https://hdl.handle.net/10481/83675</link>
<description>Structure - activity studies with histamine H3 - receptor ligands
Ganellin, C. R.; Fkyerat, A.; Hosseini, S. K.; Khalaf, Y. S.; Piripitsi, A.; Tertiuk, W.; Arrang, J. M.; Garbarg, M.; Ligneau, X.; Schwartz, J. C.
Se han sintetizado análogos de tioperamida. Los compuestos han sido ensayados in&#13;
&#13;
vitro para explorar los factores que permitan diseñar compuestos derivados de la tioperamida&#13;
&#13;
sin grupo tiourea que mejoren la penetración cerebral. Los compuestos más activos como&#13;
&#13;
H3-antagonistas contienen un átomo de nitrógeno aromático hetorocíclico sobre la cadena&#13;
&#13;
lateral. Estos compuestos se han empleado como cabeza de serie para obtener potentes&#13;
&#13;
H3-antagonistas de histarnina con estructura de ariloxietil y ariloxipropilimidazoles.&#13;
&#13;
Las relaciones estructura actividad de agonistas se han revisado brevemente. Se han&#13;
&#13;
estudiado un grupo de análogos de (S-[2-imidazol-4-il)etil]isotiourea (imetit) con el&#13;
&#13;
objeto de explorar la transición entre agonistas y antagonistas. N,N' -dibutil-[S-[3-(imidazol-&#13;
&#13;
4-il)propil]isotiourea es un muy potente antagonistas que tiene Ki=1.5 nM.; Analogues of thioperamide have been synthesised and tested in vitro on rat cerebral &#13;
cortex to explore structure-activity relationships with the intention of designing compounds &#13;
which do not possess the thiourea group of thioperamide and which may have improved &#13;
brain penetration. Compounds derived from histamine and having an aromatic nitrogen containing heterocyc1e on the side-chain amino group have been found to act as H3&#13;
-&#13;
antagonists. These have served as leads to provide aryloxyethyl- and aryloxypropylimidazoles &#13;
which are potent H3 antagonists of histamine. &#13;
Structure-activity relationships for agonists are brief1y reviewed. Analogues of the &#13;
very potent and selective agonist, imetit (S-[2-imidazol-4-yl)ethyl]isothiourea) have been &#13;
studied to explore the transition between agonist, partial agonist and antagonist. The &#13;
isosteric isourea is also a potent agonist. N,N' -Dibutyl-[S-[3-(imidazol-4-yl)propyl]isothiourea &#13;
is a very potent antagonist having K¡=1.5 nM.
</description>
<guid isPermaLink="false">https://hdl.handle.net/10481/83675</guid>
</item>
<item>
<title>A stereodivergent access to naturally occurring aminocarbasugars from (Phenylsulfonyl)-7 -oxa-bicyclo[2.2.1 ]heptane derivatives. Total synthesis of ( + )-Validamine and its CI and C2 stereoisomers</title>
<link>https://hdl.handle.net/10481/83673</link>
<description>A stereodivergent access to naturally occurring aminocarbasugars from (Phenylsulfonyl)-7 -oxa-bicyclo[2.2.1 ]heptane derivatives. Total synthesis of ( + )-Validamine and its CI and C2 stereoisomers
Arjona, O.; Plumet, J.
The total syntheses of the antibiotic validamine an its three diastereomers have been&#13;
&#13;
acomplished and their racemic penta-N-O-acetates via stereocontrolled nucleophilic epoxidation&#13;
&#13;
of polihydroxylated cyclohexenyl sulfones, obtained from (phenylsulphonyl)-7-&#13;
&#13;
oxabicyclo[2,2, l ]heptanes. The diastereoselectivity of the epoxidation can be readily&#13;
&#13;
controlled by careful choice of the hydroxyl protecting group. Ring opening of the&#13;
&#13;
resulting epoxisulfones followed by stereocontrolled introduction of an amine precursor&#13;
&#13;
led to the four C-l and C-2 diastereomers of the I-aminocarbasugars.; La epoxidación nucleofilica estereocontrolada de ciclohexenil sulfonas polidroxiladas, &#13;
obtenidas a partir de (fenilsulfonil)-7-oxabiciclo[2,2, l ] heptano s conduce a la síntesis total &#13;
del antibiótico validarnina y sus tres diastereoisómeros. La diastereoselectividad de la &#13;
epoxidación puede controlarse facilrnente mediante la elección del grupo protector del &#13;
hidroxilo. La apertura del anillo de las epoxisulfonas resultantes, seguida de la introduc ción estereocontrolada de un precursor del grupo
</description>
<guid isPermaLink="false">https://hdl.handle.net/10481/83673</guid>
</item>
<item>
<title>New developments in opioid receptors ligands</title>
<link>https://hdl.handle.net/10481/83672</link>
<description>New developments in opioid receptors ligands
Ronsisvalle, G.; Prezzavento, O.; Pasquinucci, L.; Marazzo, A.; Vittorio, F.; Pappalardo, M. S.; Bousquet, E.
Relevant developments have been achieved in the last twenty years in the search for &#13;
opioid agonists and antagonists with selectivity for each receptor subpopulation. Recently, &#13;
new benzomorphan derivatives have been synthesized and compounds with substituted &#13;
cyclopropylmethyl functionalities at N-l position showed high affinity and selectivity for &#13;
K opioid receptor subpopulations. MPCB and CCB were selected as specific K agonists. &#13;
The affinity ofCCB was two-fold the USO,488H one. Mixed peptide-heterocyclic compounds &#13;
have been derived from these compounds and important informations on binding processes &#13;
of K ligands have been obtained.; En los últimos veinte años se ha llevado a cabo una intensa investigación sobre la &#13;
búsqueda de agonistas y antagonistas selectivos de cada subtipo de receptores opiáceos. &#13;
Recientemente, se han sintetizado nuevos derivados benzomorfánicos y compuestos con &#13;
restos ciclopropilmetílicos sobre N-l que muestran alta afinidad y selectividad por los &#13;
receptores K . Los compuestos MPCB y CCB se han seleccionado como agonistas específicos K. La afinidad de CCB es dos veces mayor que la del compuesto USO,488H. De &#13;
estos compuestos se han derivado interesantes compuestos con estructura de peptidoheterocido y se han obtenido importantes informaciones sobre los procesos de binding a &#13;
los receptores K.
</description>
<guid isPermaLink="false">https://hdl.handle.net/10481/83672</guid>
</item>
<item>
<title>Past approaches to discovering new medicines</title>
<link>https://hdl.handle.net/10481/83671</link>
<description>Past approaches to discovering new medicines
Ganellin, C.; Robin, C.
Se hace una breve historia de las principales aproximaciones al descubrimiento de &#13;
nuevos fármacos. Se describen cuatro de las principales aproximaciones: productos &#13;
naturales, uso de prototipos existentes, screening farmacológico y transmisores fisiológicos.; A brief account is given of the main approaches to new drug discovery which have &#13;
been taken during the twentieth century. Four main sources for new drugs are described &#13;
and each of these is discussed in turn; they are: natural products, existing drugs, screens &#13;
and physiological transmitters.
</description>
<guid isPermaLink="false">https://hdl.handle.net/10481/83671</guid>
</item>
<item>
<title>Sulfone directed alkylative bridge cleavage of  oxabicyclic vinyl sulfones with organolithium  reagents (1)</title>
<link>https://hdl.handle.net/10481/74598</link>
<description>Sulfone directed alkylative bridge cleavage of  oxabicyclic vinyl sulfones with organolithium  reagents (1)
Arjona, O.; Plumet, J.
An efficient regio- and stereocontrolled methodology for the alkylative bridge &#13;
cleavage of oxabicyclic vinyl sulfones is described. A range of 7 -oxabicyclic[2.2.1. ]heptenyl &#13;
and 8-oxabicyclic [3.2.1.]octenyl sulfones has been found to undergo an overall syn &#13;
S~' opening when treated with a wide variety of organolithium reagents and lithium &#13;
aluminum hydride. In this manner, higWy functionalized cyclohexenyl and cycloheptenyl &#13;
sulfones, versatile synthetic intermediates, are now available in high yields. The &#13;
complete stereoselectivity encountered in the exo conjugate addition may be explained &#13;
by chelation of the organometallic reagent with the oxygen bridge and steric factors. &#13;
Furthermore, less-strained substrates allow for complete control of the addition and &#13;
elimination stages.; Se describe una interesante rotura alquilante regio-y estereocontrolada del puente de &#13;
oxabiciclo vinil sulfonas. Las 7-oxabiciclo[2.2.1] heptenil y 8-oxabiciclo [3.2.1.] octenil &#13;
sulfonas sufren aperturas syn S~' cuando se tratan con una amplia variedad de reactivos &#13;
organolíticos e hiduro de litio y aluminio. De esta forma, se obtienen ciclohexenil y &#13;
cicloheptenil sulfonas, altamente funcionalizadas, que son intermedios sintéticos versátiles. &#13;
La completa estereoselectividad encontrada en la adición conjugada exo puede explicarse &#13;
en base a la quelación del reactivo organometálico con el oxígeno puente.
This research was supported by D.G.I.C.Y.T. (Grant no. PB90-0035) and &#13;
PharmaMar S.A. (Madrid). We are grateful to the Comunidad Autónoma &#13;
Madrid and the Universidad Complutense de Madrid for doctoral fellowships &#13;
A. d. D. and A. V. respectively.
</description>
<guid isPermaLink="false">https://hdl.handle.net/10481/74598</guid>
</item>
</channel>
</rss>
